Skip to main content
Top
Published in: BMC Surgery 1/2017

Open Access 01-12-2017 | Research article

Radical antegrade modular pancreatosplenectomy versus standard procedure in the treatment of left-sided pancreatic cancer: A systemic review and meta-analysis

Authors: Feng Cao, Jia Li, Ang Li, Fei Li

Published in: BMC Surgery | Issue 1/2017

Login to get access

Abstract

Background

Radical antegrade modular pancreatosplenectomy (RAMPS), first reported by Strasberg in 2003, has attracted increasing attention in the treatment of left-sided pancreatic cancer. The limited number of cases eligible for RAMPS makes it difficult to perform any prospective randomized trial of RAMPS versus the standard procedure. Therefore, we performed this systemic review and meta-analysis of the current data to clarify the role of the RAMPS procedure.

Methods

A literature search was performed in electronic databases, including PubMed, Medline, Embase, CNKI and the Cochrane Library. Studies comparing RAMPS with the standard procedure were included in this meta-analysis. R0 resection rate, recurrence rate at the end of the follow-up, overall survival (OS) and disease-free survival (DFS) were measured as primary outcomes. Revman 5.3 was used to perform the analysis.

Results

Six retrospective cohort studies with a total number of 378 patients were included in our analysis. Meta-analysis revealed that RAMPS was correlated with higher R0 resection rates [Odds Ratio (OR) 95% confidence interval (CI), 2.19 (1.16 ~ 4.13); P = 0.02] and successful harvest of more lymph nodes [weighted mean difference (WMD) 95% CI, 7.06 (4.52 ~ 9.60); P < 0.01] compared with the standard procedure. However, no statistically significant difference was found between the procedures with respect to recurrence rates [OR 95% CI, 0.66 (0.40 ~ 1.09); P = 0.10], OS [Hazard ratio (HR) 95% CI, 0.65 (0.42 ~ 1.00); P = 0.05] or DFS [HR 95% CI, 1.02 (0.62 ~ 1.68); P = 0.93].

Conclusions

RAMPS is safe and oncologically superior to the standard procedure for the treatment of left-sided pancreatic cancer. However, high-grade evidence will be necessary to confirm the potential survival benefits of RAMPS.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wu X, Tao R, Lei R, Han B, Cheng D, Shen B, Peng C. Distal pancreatectomy combined with celiac axis resection in treatment of carcinoma of the body/tail of the pancreas: a single-center experience. Ann Surg Oncol. 2010;17(5):1359–66.CrossRefPubMed Wu X, Tao R, Lei R, Han B, Cheng D, Shen B, Peng C. Distal pancreatectomy combined with celiac axis resection in treatment of carcinoma of the body/tail of the pancreas: a single-center experience. Ann Surg Oncol. 2010;17(5):1359–66.CrossRefPubMed
2.
go back to reference Yamamoto J, Saiura A, Koga R, Seki M, Katori M, Kato Y, Sakamoto Y, Kokudo N, Yamaguchi T. Improved survival of left-sided pancreas cancer after surgery. Jpn J Clin Oncol. 2010;40(6):530–6.CrossRefPubMed Yamamoto J, Saiura A, Koga R, Seki M, Katori M, Kato Y, Sakamoto Y, Kokudo N, Yamaguchi T. Improved survival of left-sided pancreas cancer after surgery. Jpn J Clin Oncol. 2010;40(6):530–6.CrossRefPubMed
3.
go back to reference Reddy SK, Tyler DS, Pappas TN, Clary BM. Extended resection for pancreatic adenocarcinoma. Oncologist. 2007;12(6):654–63.CrossRefPubMed Reddy SK, Tyler DS, Pappas TN, Clary BM. Extended resection for pancreatic adenocarcinoma. Oncologist. 2007;12(6):654–63.CrossRefPubMed
4.
go back to reference van Gulik TM, Nakao A, Obertop H. Extended resection for pancreatic adenocarcinoma. HPB (Oxford). 2002;4(3):101–3.CrossRef van Gulik TM, Nakao A, Obertop H. Extended resection for pancreatic adenocarcinoma. HPB (Oxford). 2002;4(3):101–3.CrossRef
5.
go back to reference Dalton RR, Sarr MG, van Heerden JA, Colby TV. Carcinoma of the body and tail of the pancreas: is curative resection justified? Surgery. 1992;111(5):489–94.PubMed Dalton RR, Sarr MG, van Heerden JA, Colby TV. Carcinoma of the body and tail of the pancreas: is curative resection justified? Surgery. 1992;111(5):489–94.PubMed
6.
go back to reference Pandanaboyana S, Bell R, Windsor J. Artery first approach to pancreatoduodenectomy: current status. ANZ J Surg. 2016;86(3):127–32.CrossRefPubMed Pandanaboyana S, Bell R, Windsor J. Artery first approach to pancreatoduodenectomy: current status. ANZ J Surg. 2016;86(3):127–32.CrossRefPubMed
7.
go back to reference Inoue Y, Saiura A, Yoshioka R, Ono Y, Takahashi M, Arita J, Takahashi Y, Koga R. Pancreatoduodenectomy with systematic Mesopancreas dissection using a Supracolic anterior artery-first approach. Ann Surg. 2015;262(6):1092–101.CrossRefPubMed Inoue Y, Saiura A, Yoshioka R, Ono Y, Takahashi M, Arita J, Takahashi Y, Koga R. Pancreatoduodenectomy with systematic Mesopancreas dissection using a Supracolic anterior artery-first approach. Ann Surg. 2015;262(6):1092–101.CrossRefPubMed
8.
go back to reference Nagakawa Y, Hosokawa Y, Sahara Y, Takishita C, Nakajima T, Hijikata Y, Tago T, Kasuya K, Tsuchida A. A novel “artery first” approach allowing safe resection in laparoscopic Pancreaticoduodenectomy: the Uncinate process first approach. Hepato-Gastroenterology. 2015;62(140):1037–40.PubMed Nagakawa Y, Hosokawa Y, Sahara Y, Takishita C, Nakajima T, Hijikata Y, Tago T, Kasuya K, Tsuchida A. A novel “artery first” approach allowing safe resection in laparoscopic Pancreaticoduodenectomy: the Uncinate process first approach. Hepato-Gastroenterology. 2015;62(140):1037–40.PubMed
9.
go back to reference Pittau G, Sanchez-Cabus S, Laurenzi A, Gelli M, Cunha AS. Laparoscopic Pancreaticoduodenectomy: right posterior superior mesenteric artery “first” approach. Ann Surg Oncol. 2015;22(Suppl 3):S345–8.CrossRefPubMed Pittau G, Sanchez-Cabus S, Laurenzi A, Gelli M, Cunha AS. Laparoscopic Pancreaticoduodenectomy: right posterior superior mesenteric artery “first” approach. Ann Surg Oncol. 2015;22(Suppl 3):S345–8.CrossRefPubMed
10.
go back to reference Xing-Mao Z, Hua F, Jian-Tao K, Xin-Xue Z, Ping L, Yang D, Qiang H. Resection of portal and/or superior mesenteric vein and reconstruction by using allogeneic vein for pT3 pancreatic cancer. J Gastroenterol Hepatol. 2016;31(8):1498–503.CrossRef Xing-Mao Z, Hua F, Jian-Tao K, Xin-Xue Z, Ping L, Yang D, Qiang H. Resection of portal and/or superior mesenteric vein and reconstruction by using allogeneic vein for pT3 pancreatic cancer. J Gastroenterol Hepatol. 2016;31(8):1498–503.CrossRef
11.
go back to reference Ramacciato G, Nigri G, Petrucciani N, Pinna AD, Ravaioli M, Jovine E, Minni F, Grazi GL, Chirletti P, Tisone G, et al. Pancreatectomy with mesenteric and portal vein resection for borderline Resectable pancreatic cancer: multicenter study of 406 patients. Ann Surg Oncol. 2016;23(6):2028–37.CrossRefPubMed Ramacciato G, Nigri G, Petrucciani N, Pinna AD, Ravaioli M, Jovine E, Minni F, Grazi GL, Chirletti P, Tisone G, et al. Pancreatectomy with mesenteric and portal vein resection for borderline Resectable pancreatic cancer: multicenter study of 406 patients. Ann Surg Oncol. 2016;23(6):2028–37.CrossRefPubMed
12.
go back to reference Murakami Y, Satoi S, Motoi F, Sho M, Kawai M, Matsumoto I, Honda G. Portal or superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head carcinoma. Br J Surg. 2015;102(7):837–46.CrossRefPubMed Murakami Y, Satoi S, Motoi F, Sho M, Kawai M, Matsumoto I, Honda G. Portal or superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head carcinoma. Br J Surg. 2015;102(7):837–46.CrossRefPubMed
13.
go back to reference Wang WL, Ye S, Yan S, Shen Y, Zhang M, Wu J, Zheng SS. Pancreaticoduodenectomy with portal vein/superior mesenteric vein resection for patients with pancreatic cancer with venous invasion. Hepatobiliary Pancreat Dis Int. 2015;14(4):429–35.CrossRefPubMed Wang WL, Ye S, Yan S, Shen Y, Zhang M, Wu J, Zheng SS. Pancreaticoduodenectomy with portal vein/superior mesenteric vein resection for patients with pancreatic cancer with venous invasion. Hepatobiliary Pancreat Dis Int. 2015;14(4):429–35.CrossRefPubMed
14.
go back to reference Jingu K, Tanabe T, Nemoto K, Ariga H, Umezawa R, Ogawa Y, Takeda K, Koto M, Sugawara T, Kubozono M, et al. Intraoperative radiotherapy for pancreatic cancer: 30-year experience in a single institution in Japan. Int J Radiat Oncol Biol Phys. 2012;83(4):e507–11.CrossRefPubMed Jingu K, Tanabe T, Nemoto K, Ariga H, Umezawa R, Ogawa Y, Takeda K, Koto M, Sugawara T, Kubozono M, et al. Intraoperative radiotherapy for pancreatic cancer: 30-year experience in a single institution in Japan. Int J Radiat Oncol Biol Phys. 2012;83(4):e507–11.CrossRefPubMed
15.
go back to reference Ogawa K, Karasawa K, Ito Y, Ogawa Y, Jingu K, Onishi H, Aoki S, Wada H, Kokubo M, Etoh H, et al. Intraoperative radiotherapy for resected pancreatic cancer: a multi-institutional retrospective analysis of 210 patients. Int J Radiat Oncol Biol Phys. 2010;77(3):734–42.CrossRefPubMed Ogawa K, Karasawa K, Ito Y, Ogawa Y, Jingu K, Onishi H, Aoki S, Wada H, Kokubo M, Etoh H, et al. Intraoperative radiotherapy for resected pancreatic cancer: a multi-institutional retrospective analysis of 210 patients. Int J Radiat Oncol Biol Phys. 2010;77(3):734–42.CrossRefPubMed
16.
go back to reference Hirata T, Teshima T, Nishiyama K, Ogawa K, Otani K, Kawaguchi Y, Konishi K, Tomita Y, Takahashi H, Ohigashi H, et al. Histopathological effects of preoperative chemoradiotherapy for pancreatic cancer: an analysis for the impact of radiation and gemcitabine doses. Radiother Oncol. 2015;114(1):122–7.CrossRefPubMed Hirata T, Teshima T, Nishiyama K, Ogawa K, Otani K, Kawaguchi Y, Konishi K, Tomita Y, Takahashi H, Ohigashi H, et al. Histopathological effects of preoperative chemoradiotherapy for pancreatic cancer: an analysis for the impact of radiation and gemcitabine doses. Radiother Oncol. 2015;114(1):122–7.CrossRefPubMed
17.
go back to reference Eguchi H, Nagano H, Tanemura M, Takeda Y, Marubashi S, Kobayashi S, Kawamoto K, Wada H, Hama N, Akita H, et al. Preoperative chemoradiotherapy, surgery and adjuvant therapy for resectable pancreatic cancer. Hepato-Gastroenterology. 2013;60(124):904–11.PubMed Eguchi H, Nagano H, Tanemura M, Takeda Y, Marubashi S, Kobayashi S, Kawamoto K, Wada H, Hama N, Akita H, et al. Preoperative chemoradiotherapy, surgery and adjuvant therapy for resectable pancreatic cancer. Hepato-Gastroenterology. 2013;60(124):904–11.PubMed
18.
go back to reference Vento P, Mustonen H, Joensuu T, Karkkainen P, Kivilaakso E, Kiviluoto T. Impact of preoperative chemoradiotherapy on survival in patients with resectable pancreatic cancer. World J Gastroenterol. 2007;13(21):2945–51.CrossRefPubMedPubMedCentral Vento P, Mustonen H, Joensuu T, Karkkainen P, Kivilaakso E, Kiviluoto T. Impact of preoperative chemoradiotherapy on survival in patients with resectable pancreatic cancer. World J Gastroenterol. 2007;13(21):2945–51.CrossRefPubMedPubMedCentral
19.
go back to reference Strasberg SM, Drebin JA, Linehan D. Radical antegrade modular pancreatosplenectomy. Surgery. 2003;133(5):521–7.CrossRefPubMed Strasberg SM, Drebin JA, Linehan D. Radical antegrade modular pancreatosplenectomy. Surgery. 2003;133(5):521–7.CrossRefPubMed
20.
go back to reference Abe T, Ohuchida K, Miyasaka Y, Ohtsuka T, Oda Y, Nakamura M. Comparison of surgical outcomes between radical Antegrade modular Pancreatosplenectomy (RAMPS) and standard retrograde Pancreatosplenectomy (SPRS) for left-sided pancreatic cancer. World J Surg. 2016;40(9):2267–75.CrossRefPubMed Abe T, Ohuchida K, Miyasaka Y, Ohtsuka T, Oda Y, Nakamura M. Comparison of surgical outcomes between radical Antegrade modular Pancreatosplenectomy (RAMPS) and standard retrograde Pancreatosplenectomy (SPRS) for left-sided pancreatic cancer. World J Surg. 2016;40(9):2267–75.CrossRefPubMed
21.
go back to reference Murakawa M, Aoyama T, Asari M, Katayama Y, Yamaoku K, Kanazawa A, Higuchi A, Shiozawa M, Kobayashi S, Ueno M, et al. The short- and long-term outcomes of radical antegrade modular pancreatosplenectomy for adenocarcinoma of the body and tail of the pancreas. BMC Surg. 2015;15:120.CrossRefPubMedPubMedCentral Murakawa M, Aoyama T, Asari M, Katayama Y, Yamaoku K, Kanazawa A, Higuchi A, Shiozawa M, Kobayashi S, Ueno M, et al. The short- and long-term outcomes of radical antegrade modular pancreatosplenectomy for adenocarcinoma of the body and tail of the pancreas. BMC Surg. 2015;15:120.CrossRefPubMedPubMedCentral
22.
go back to reference Ome Y, Hashida K, Yokota M, Nagahisa Y, Michio O, Kawamoto K. Laparoscopic radical antegrade modular pancreatosplenectomy for left-sided pancreatic cancer using the ligament of Treitz approach. Surg Endosc. 2017. doi:10.1007/s00464-017-5561-6. [Epub ahead of print]. Ome Y, Hashida K, Yokota M, Nagahisa Y, Michio O, Kawamoto K. Laparoscopic radical antegrade modular pancreatosplenectomy for left-sided pancreatic cancer using the ligament of Treitz approach. Surg Endosc. 2017. doi:10.​1007/​s00464-017-5561-6. [Epub ahead of print].
23.
go back to reference Han DH, Kang CM, Lee WJ, Chi HS. A five-year survivor without recurrence following robotic anterior radical antegrade modular pancreatosplenectomy for a well-selected left-sided pancreatic cancer. Yonsei Med J. 2014;55(1):276–9.CrossRefPubMed Han DH, Kang CM, Lee WJ, Chi HS. A five-year survivor without recurrence following robotic anterior radical antegrade modular pancreatosplenectomy for a well-selected left-sided pancreatic cancer. Yonsei Med J. 2014;55(1):276–9.CrossRefPubMed
24.
go back to reference Park HJ, You DD, Choi DW, Heo JS, Choi SH. Role of radical antegrade modular pancreatosplenectomy for adenocarcinoma of the body and tail of the pancreas. World J Surg. 2014;38(1):186–93.CrossRefPubMed Park HJ, You DD, Choi DW, Heo JS, Choi SH. Role of radical antegrade modular pancreatosplenectomy for adenocarcinoma of the body and tail of the pancreas. World J Surg. 2014;38(1):186–93.CrossRefPubMed
25.
go back to reference Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.CrossRefPubMed Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.CrossRefPubMed
26.
go back to reference Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16.CrossRefPubMedPubMedCentral Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16.CrossRefPubMedPubMedCentral
27.
go back to reference Trottman P, Swett K, Shen P, Sirintrapun J. Comparison of standard distal pancreatectomy and splenectomy with radical antegrade modular pancreatosplenectomy. Am Surg. 2014;80(3):295–300.PubMedPubMedCentral Trottman P, Swett K, Shen P, Sirintrapun J. Comparison of standard distal pancreatectomy and splenectomy with radical antegrade modular pancreatosplenectomy. Am Surg. 2014;80(3):295–300.PubMedPubMedCentral
28.
go back to reference Latorre M, Ziparo V, Nigri G, Balducci G, Cavallini M, Ramacciato G. Standard retrograde pancreatosplenectomy versus radical antegrade modular pancreatosplenectomy for body and tail pancreatic adenocarcinoma. Am Surg. 2013;79(11):1154–8.PubMed Latorre M, Ziparo V, Nigri G, Balducci G, Cavallini M, Ramacciato G. Standard retrograde pancreatosplenectomy versus radical antegrade modular pancreatosplenectomy for body and tail pancreatic adenocarcinoma. Am Surg. 2013;79(11):1154–8.PubMed
29.
go back to reference Xu D, Jiang KR, Lu ZP, Guo F, Chen JM, Wei JS, Yin J, Zhang K, Wu PF, Cai BB, Lv N, Miao Y. Clinical effect of radical antegrade modular pancreatosplenectomy for carcinoma of pancreatic body and tail. Zhong Hua Xiao Hua Wai Ke Za Zhi. 2016;15(6):567–73. Xu D, Jiang KR, Lu ZP, Guo F, Chen JM, Wei JS, Yin J, Zhang K, Wu PF, Cai BB, Lv N, Miao Y. Clinical effect of radical antegrade modular pancreatosplenectomy for carcinoma of pancreatic body and tail. Zhong Hua Xiao Hua Wai Ke Za Zhi. 2016;15(6):567–73.
30.
go back to reference Kim EY, You YK, Kim DG, Hong TH. Initial experience with radical antegrade modular pancreatosplenectomy in a single institution. Ann Surg Treat Res. 2016;91(1):29–36.CrossRefPubMedPubMedCentral Kim EY, You YK, Kim DG, Hong TH. Initial experience with radical antegrade modular pancreatosplenectomy in a single institution. Ann Surg Treat Res. 2016;91(1):29–36.CrossRefPubMedPubMedCentral
31.
go back to reference Grossman JG, Fields RC, Hawkins WG, Strasberg SM. Single institution results of radical antegrade modular pancreatosplenectomy for adenocarcinoma of the body and tail of pancreas in 78 patients. J Hepatobiliary Pancreat Sci. 2016;23(7):432–41.CrossRefPubMed Grossman JG, Fields RC, Hawkins WG, Strasberg SM. Single institution results of radical antegrade modular pancreatosplenectomy for adenocarcinoma of the body and tail of pancreas in 78 patients. J Hepatobiliary Pancreat Sci. 2016;23(7):432–41.CrossRefPubMed
32.
go back to reference Strasberg SM, Linehan DC, Hawkins WG. Radical antegrade modular pancreatosplenectomy procedure for adenocarcinoma of the body and tail of the pancreas: ability to obtain negative tangential margins. J Am Coll Surg. 2007;204(2):244–9.CrossRefPubMed Strasberg SM, Linehan DC, Hawkins WG. Radical antegrade modular pancreatosplenectomy procedure for adenocarcinoma of the body and tail of the pancreas: ability to obtain negative tangential margins. J Am Coll Surg. 2007;204(2):244–9.CrossRefPubMed
33.
go back to reference Fujita T, Nakagohri T, Gotohda N, Takahashi S, Konishi M, Kojima M, Kinoshita T. Evaluation of the prognostic factors and significance of lymph node status in invasive ductal carcinoma of the body or tail of the pancreas. Pancreas. 2010;39(1):e48–54.CrossRefPubMed Fujita T, Nakagohri T, Gotohda N, Takahashi S, Konishi M, Kojima M, Kinoshita T. Evaluation of the prognostic factors and significance of lymph node status in invasive ductal carcinoma of the body or tail of the pancreas. Pancreas. 2010;39(1):e48–54.CrossRefPubMed
34.
go back to reference Shimada K, Sakamoto Y, Sano T, Kosuge T. Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail. Surgery. 2006;139(3):288–95.CrossRefPubMed Shimada K, Sakamoto Y, Sano T, Kosuge T. Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail. Surgery. 2006;139(3):288–95.CrossRefPubMed
35.
go back to reference Tol JA, Gouma DJ, Bassi C, Dervenis C, Montorsi M, Adham M, Andren-Sandberg A, Asbun HJ, Bockhorn M, Buchler MW, et al. Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the international study group on pancreatic surgery (ISGPS). Surgery. 2014;156(3):591–600.CrossRefPubMed Tol JA, Gouma DJ, Bassi C, Dervenis C, Montorsi M, Adham M, Andren-Sandberg A, Asbun HJ, Bockhorn M, Buchler MW, et al. Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the international study group on pancreatic surgery (ISGPS). Surgery. 2014;156(3):591–600.CrossRefPubMed
36.
go back to reference Aosasa S, Nishikawa M, Hoshikawa M, Noro T, Yamamoto J. Inframesocolic superior mesenteric artery first approach as an introductory procedure of radical Antegrade modular Pancreatosplenectomy for carcinoma of the pancreatic body and tail. J Gastrointest Surg. 2016;20(2):450–4.CrossRefPubMed Aosasa S, Nishikawa M, Hoshikawa M, Noro T, Yamamoto J. Inframesocolic superior mesenteric artery first approach as an introductory procedure of radical Antegrade modular Pancreatosplenectomy for carcinoma of the pancreatic body and tail. J Gastrointest Surg. 2016;20(2):450–4.CrossRefPubMed
37.
go back to reference Kawabata Y, Hayashi H, Takai K, Kidani A, Tajima Y. Superior mesenteric artery-first approach in radical antegrade modular pancreatosplenectomy for borderline resectable pancreatic cancer: a technique to obtain negative tangential margins. J Am Coll Surg. 2015;220(5):e49–54.CrossRefPubMed Kawabata Y, Hayashi H, Takai K, Kidani A, Tajima Y. Superior mesenteric artery-first approach in radical antegrade modular pancreatosplenectomy for borderline resectable pancreatic cancer: a technique to obtain negative tangential margins. J Am Coll Surg. 2015;220(5):e49–54.CrossRefPubMed
38.
go back to reference Kitagawa H, Tajima H, Nakagawara H, Makino I, Miyashita T, Terakawa H, Nakanuma S, Hayashi H, Takamura H, Ohta T. A modification of radical antegrade modular pancreatosplenectomy for adenocarcinoma of the left pancreas: significance of en bloc resection including the anterior renal fascia. World J Surg. 2014;38(9):2448–54.CrossRefPubMedPubMedCentral Kitagawa H, Tajima H, Nakagawara H, Makino I, Miyashita T, Terakawa H, Nakanuma S, Hayashi H, Takamura H, Ohta T. A modification of radical antegrade modular pancreatosplenectomy for adenocarcinoma of the left pancreas: significance of en bloc resection including the anterior renal fascia. World J Surg. 2014;38(9):2448–54.CrossRefPubMedPubMedCentral
39.
go back to reference Lee SH, Kang CM, Hwang HK, Choi SH, Lee WJ, Chi HS. Minimally invasive RAMPS in well-selected left-sided pancreatic cancer within Yonsei criteria: long-term (>median 3 years) oncologic outcomes. Surg Endosc. 2014;28(10):2848–55.CrossRefPubMed Lee SH, Kang CM, Hwang HK, Choi SH, Lee WJ, Chi HS. Minimally invasive RAMPS in well-selected left-sided pancreatic cancer within Yonsei criteria: long-term (>median 3 years) oncologic outcomes. Surg Endosc. 2014;28(10):2848–55.CrossRefPubMed
40.
go back to reference Poves I, Burdio F, Membrilla E, Alonso S, Grande L. Laparoscopic radical antegrade modular pancreatosplenectomy. Cir Esp. 2010;88(1):51–3.CrossRefPubMed Poves I, Burdio F, Membrilla E, Alonso S, Grande L. Laparoscopic radical antegrade modular pancreatosplenectomy. Cir Esp. 2010;88(1):51–3.CrossRefPubMed
41.
go back to reference Kang CM, Kim DH, Lee WJ. Ten years of experience with resection of left-sided pancreatic ductal adenocarcinoma: evolution and initial experience to a laparoscopic approach. Surg Endosc. 2010;24(7):1533–41.CrossRefPubMed Kang CM, Kim DH, Lee WJ. Ten years of experience with resection of left-sided pancreatic ductal adenocarcinoma: evolution and initial experience to a laparoscopic approach. Surg Endosc. 2010;24(7):1533–41.CrossRefPubMed
42.
go back to reference Ikegami T, Maeda T, Oki E, Kayashima H, Ohgaki K, Sakaguchi Y, Shirabe K, Maehara Y. Antegrade en bloc distal pancreatectomy with plexus hanging maneuver. J Gastrointest Surg. 2011;15(4):690–3.CrossRefPubMed Ikegami T, Maeda T, Oki E, Kayashima H, Ohgaki K, Sakaguchi Y, Shirabe K, Maehara Y. Antegrade en bloc distal pancreatectomy with plexus hanging maneuver. J Gastrointest Surg. 2011;15(4):690–3.CrossRefPubMed
43.
go back to reference Mitchem JB, Hamilton N, Gao F, Hawkins WG, Linehan DC, Strasberg SM. Long-term results of resection of adenocarcinoma of the body and tail of the pancreas using radical antegrade modular pancreatosplenectomy procedure. J Am Coll Surg. 2012;214(1):46–52.CrossRefPubMed Mitchem JB, Hamilton N, Gao F, Hawkins WG, Linehan DC, Strasberg SM. Long-term results of resection of adenocarcinoma of the body and tail of the pancreas using radical antegrade modular pancreatosplenectomy procedure. J Am Coll Surg. 2012;214(1):46–52.CrossRefPubMed
44.
go back to reference Chang YR, Han SS, Park SJ, Lee SD, Yoo TS, Kim YK, Kim TH, Woo SM, Lee WJ, Hong EK. Surgical outcome of pancreatic cancer using radical antegrade modular pancreatosplenectomy procedure. World J Gastroenterol. 2012;18(39):5595–600.CrossRefPubMedPubMedCentral Chang YR, Han SS, Park SJ, Lee SD, Yoo TS, Kim YK, Kim TH, Woo SM, Lee WJ, Hong EK. Surgical outcome of pancreatic cancer using radical antegrade modular pancreatosplenectomy procedure. World J Gastroenterol. 2012;18(39):5595–600.CrossRefPubMedPubMedCentral
45.
go back to reference Kim SH, Kang CM, Satoi S, Sho M, Nakamura Y, Lee WJ. Proposal for splenectomy-omitting radical distal pancreatectomy in well-selected left-sided pancreatic cancer: multicenter survey study. J Hepatobiliary Pancreat Sci. 2013;20(3):375–81.CrossRefPubMed Kim SH, Kang CM, Satoi S, Sho M, Nakamura Y, Lee WJ. Proposal for splenectomy-omitting radical distal pancreatectomy in well-selected left-sided pancreatic cancer: multicenter survey study. J Hepatobiliary Pancreat Sci. 2013;20(3):375–81.CrossRefPubMed
46.
go back to reference Rosso E, Langella S, Addeo P, Nobili C, Oussoultzoglou E, Jaeck D, Bachellier P. A safe technique for radical antegrade modular pancreatosplenectomy with venous resection for pancreatic cancer. J Am Coll Surg. 2013;217(5):e35–9.CrossRefPubMed Rosso E, Langella S, Addeo P, Nobili C, Oussoultzoglou E, Jaeck D, Bachellier P. A safe technique for radical antegrade modular pancreatosplenectomy with venous resection for pancreatic cancer. J Am Coll Surg. 2013;217(5):e35–9.CrossRefPubMed
Metadata
Title
Radical antegrade modular pancreatosplenectomy versus standard procedure in the treatment of left-sided pancreatic cancer: A systemic review and meta-analysis
Authors
Feng Cao
Jia Li
Ang Li
Fei Li
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Surgery / Issue 1/2017
Electronic ISSN: 1471-2482
DOI
https://doi.org/10.1186/s12893-017-0259-1

Other articles of this Issue 1/2017

BMC Surgery 1/2017 Go to the issue